Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care: a matched cohort study.

Fredrik MethiJon Michael GranMorten ValbergJonas Minet KingeKjetil TelleKarin Magnusson

Published in: BMC medicine (2023)

Our findings suggest that a 3rd dose of SARS-CoV-2 mRNA vaccine administered 20-30 weeks after the 2nd dose may reduce the incidence of medical complaints. It may also reduce the COVID-19-related burden on primary healthcare services.

Keyphrases

sars cov
healthcare
primary care
respiratory syndrome coronavirus
risk factors
coronavirus disease
binding protein